
from
Independent International Investment Research3 page report
published Oct 29, 2009
Price
$15.00 available for immediate download
Report Overview
Search Inside
About
Independent International Inve...
GlaxoSmithKline PLC’s (GSK) results were in line with our estimates in 3Q 09. Therefore, our fundamental outlook remains unchanged and we maintain our BUY rating for the common stock...
|
| Source: | IIR Group PLC
|
| Document ID: | GER25536SN
|
| Country: | United Kingdom
|
| Industry: | Pharmaceutical
|
| Ticker: | GSK=GB
|
| Primary ISIN: | US37733W1053
|
| Primary Sedol: | 2374112
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
Independent International Investment Research is the UK's leading source of truly impartial research and strategy for global equities and currencies.